History of psychosis and mania, and outcomes after kidney transplantation - a retrospective study

M.Z. Molnar, J.D. Eason, A. Gaipov, M. Talwar, P.K. Potukuchi, K. Joglekar, A. Remport, Z. Mathe, I. Mucsi, M. Novak, K. Kalantar-Zadeh, C.P. Kovesdy

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

History of psychosis or mania, if uncontrolled, both represent relative contraindications for kidney transplantation. We examined 3680 US veterans who underwent kidney transplantation. The diagnosis of history of psychosis/mania was based on a validated algorithm. Measured confounders were used to create a propensity score-matched cohort (n = 442). Associations between pretransplantation psychosis/mania and death with functioning graft, all-cause death, graft loss, and rejection were examined in survival models and logistic regression models. Post-transplant medication nonadherence was assessed using proportion of days covered (PDC) for tacrolimus and mycophenolic acid in both groups. The mean ± SD age of the cohort at baseline was 61 ± 11 years, 92% were male, and 66% and 27% of patients were white and African-American, respectively. Compared to patients without history of psychosis/mania, patients with a history of psychosis/mania had similar risk of death with functioning graft [subhazard ratio (SHR) (95% confidence interval (CI)): 0.94(0.42–2.09)], all-cause death [hazard ratio (95% CI): 1.04 (0.51–2.14)], graft loss [SHR (95% CI): 1.07 (0.45–2.57)], and rejection [odds ratio(95% CI): 1.23(0.60–2.53)]. Moreover, there was no difference in immunosuppressive drug PDC in patients with and without history of psychosis/mania (PDC: 76 ± 21% vs. 78 ± 19%, P = 0.529 for tacrolimus; PDC: 78 ± 17% vs. 79 ± 18%, P = 0.666 for mycophenolic acid). After careful selection, pretransplantation psychosis/mania is not associated with adverse outcomes in kidney transplant recipients. © 2018 Steunstichting ESOT
Original languageEnglish
Pages (from-to)554-565
Number of pages12
JournalTransplant International
Volume31
Issue number5
DOIs
Publication statusPublished - 2018

Fingerprint

Bipolar Disorder
Psychotic Disorders
Kidney Transplantation
Retrospective Studies
Confidence Intervals
Mycophenolic Acid
Transplants
Tacrolimus
Cause of Death
Logistic Models
Propensity Score
Medication Adherence
Graft Rejection
Veterans
Immunosuppressive Agents
African Americans
Odds Ratio
Kidney
Survival
Pharmaceutical Preparations

Keywords

  • mycophenolic acid
  • tacrolimus, adult
  • African American
  • age distribution
  • all cause mortality
  • Article
  • Caucasian
  • controlled study
  • disease association
  • female
  • graft failure
  • graft rejection
  • human
  • kidney transplantation
  • major clinical study
  • male
  • mania
  • medication compliance
  • priority journal
  • psychosis
  • risk assessment
  • risk factor
  • sex difference
  • treatment outcome
  • veteran
  • aged
  • bipolar disorder
  • cause of death
  • complication
  • middle aged
  • mortality
  • retrospective study, Aged
  • Bipolar Disorder
  • Cause of Death
  • Female
  • Graft Rejection
  • Humans
  • Kidney Transplantation
  • Male
  • Medication Adherence
  • Middle Aged
  • Psychotic Disorders
  • Retrospective Studies

Cite this

Molnar, M. Z., Eason, J. D., Gaipov, A., Talwar, M., Potukuchi, P. K., Joglekar, K., ... Kovesdy, C. P. (2018). History of psychosis and mania, and outcomes after kidney transplantation - a retrospective study. Transplant International, 31(5), 554-565. https://doi.org/10.1111/tri.13127

History of psychosis and mania, and outcomes after kidney transplantation - a retrospective study. / Molnar, M.Z.; Eason, J.D.; Gaipov, A.; Talwar, M.; Potukuchi, P.K.; Joglekar, K.; Remport, A.; Mathe, Z.; Mucsi, I.; Novak, M.; Kalantar-Zadeh, K.; Kovesdy, C.P.

In: Transplant International, Vol. 31, No. 5, 2018, p. 554-565.

Research output: Contribution to journalArticle

Molnar, MZ, Eason, JD, Gaipov, A, Talwar, M, Potukuchi, PK, Joglekar, K, Remport, A, Mathe, Z, Mucsi, I, Novak, M, Kalantar-Zadeh, K & Kovesdy, CP 2018, 'History of psychosis and mania, and outcomes after kidney transplantation - a retrospective study', Transplant International, vol. 31, no. 5, pp. 554-565. https://doi.org/10.1111/tri.13127
Molnar, M.Z. ; Eason, J.D. ; Gaipov, A. ; Talwar, M. ; Potukuchi, P.K. ; Joglekar, K. ; Remport, A. ; Mathe, Z. ; Mucsi, I. ; Novak, M. ; Kalantar-Zadeh, K. ; Kovesdy, C.P. / History of psychosis and mania, and outcomes after kidney transplantation - a retrospective study. In: Transplant International. 2018 ; Vol. 31, No. 5. pp. 554-565.
@article{8a0826a113754202995a3c1b15fa51ed,
title = "History of psychosis and mania, and outcomes after kidney transplantation - a retrospective study",
abstract = "History of psychosis or mania, if uncontrolled, both represent relative contraindications for kidney transplantation. We examined 3680 US veterans who underwent kidney transplantation. The diagnosis of history of psychosis/mania was based on a validated algorithm. Measured confounders were used to create a propensity score-matched cohort (n = 442). Associations between pretransplantation psychosis/mania and death with functioning graft, all-cause death, graft loss, and rejection were examined in survival models and logistic regression models. Post-transplant medication nonadherence was assessed using proportion of days covered (PDC) for tacrolimus and mycophenolic acid in both groups. The mean ± SD age of the cohort at baseline was 61 ± 11 years, 92{\%} were male, and 66{\%} and 27{\%} of patients were white and African-American, respectively. Compared to patients without history of psychosis/mania, patients with a history of psychosis/mania had similar risk of death with functioning graft [subhazard ratio (SHR) (95{\%} confidence interval (CI)): 0.94(0.42–2.09)], all-cause death [hazard ratio (95{\%} CI): 1.04 (0.51–2.14)], graft loss [SHR (95{\%} CI): 1.07 (0.45–2.57)], and rejection [odds ratio(95{\%} CI): 1.23(0.60–2.53)]. Moreover, there was no difference in immunosuppressive drug PDC in patients with and without history of psychosis/mania (PDC: 76 ± 21{\%} vs. 78 ± 19{\%}, P = 0.529 for tacrolimus; PDC: 78 ± 17{\%} vs. 79 ± 18{\%}, P = 0.666 for mycophenolic acid). After careful selection, pretransplantation psychosis/mania is not associated with adverse outcomes in kidney transplant recipients. {\circledC} 2018 Steunstichting ESOT",
keywords = "mycophenolic acid, tacrolimus, adult, African American, age distribution, all cause mortality, Article, Caucasian, controlled study, disease association, female, graft failure, graft rejection, human, kidney transplantation, major clinical study, male, mania, medication compliance, priority journal, psychosis, risk assessment, risk factor, sex difference, treatment outcome, veteran, aged, bipolar disorder, cause of death, complication, middle aged, mortality, retrospective study, Aged, Bipolar Disorder, Cause of Death, Female, Graft Rejection, Humans, Kidney Transplantation, Male, Medication Adherence, Middle Aged, Psychotic Disorders, Retrospective Studies",
author = "M.Z. Molnar and J.D. Eason and A. Gaipov and M. Talwar and P.K. Potukuchi and K. Joglekar and A. Remport and Z. Mathe and I. Mucsi and M. Novak and K. Kalantar-Zadeh and C.P. Kovesdy",
note = "cited By 0",
year = "2018",
doi = "10.1111/tri.13127",
language = "English",
volume = "31",
pages = "554--565",
journal = "Transplant International",
issn = "0934-0874",
publisher = "Blackwell Publishing Ltd.",
number = "5",

}

TY - JOUR

T1 - History of psychosis and mania, and outcomes after kidney transplantation - a retrospective study

AU - Molnar, M.Z.

AU - Eason, J.D.

AU - Gaipov, A.

AU - Talwar, M.

AU - Potukuchi, P.K.

AU - Joglekar, K.

AU - Remport, A.

AU - Mathe, Z.

AU - Mucsi, I.

AU - Novak, M.

AU - Kalantar-Zadeh, K.

AU - Kovesdy, C.P.

N1 - cited By 0

PY - 2018

Y1 - 2018

N2 - History of psychosis or mania, if uncontrolled, both represent relative contraindications for kidney transplantation. We examined 3680 US veterans who underwent kidney transplantation. The diagnosis of history of psychosis/mania was based on a validated algorithm. Measured confounders were used to create a propensity score-matched cohort (n = 442). Associations between pretransplantation psychosis/mania and death with functioning graft, all-cause death, graft loss, and rejection were examined in survival models and logistic regression models. Post-transplant medication nonadherence was assessed using proportion of days covered (PDC) for tacrolimus and mycophenolic acid in both groups. The mean ± SD age of the cohort at baseline was 61 ± 11 years, 92% were male, and 66% and 27% of patients were white and African-American, respectively. Compared to patients without history of psychosis/mania, patients with a history of psychosis/mania had similar risk of death with functioning graft [subhazard ratio (SHR) (95% confidence interval (CI)): 0.94(0.42–2.09)], all-cause death [hazard ratio (95% CI): 1.04 (0.51–2.14)], graft loss [SHR (95% CI): 1.07 (0.45–2.57)], and rejection [odds ratio(95% CI): 1.23(0.60–2.53)]. Moreover, there was no difference in immunosuppressive drug PDC in patients with and without history of psychosis/mania (PDC: 76 ± 21% vs. 78 ± 19%, P = 0.529 for tacrolimus; PDC: 78 ± 17% vs. 79 ± 18%, P = 0.666 for mycophenolic acid). After careful selection, pretransplantation psychosis/mania is not associated with adverse outcomes in kidney transplant recipients. © 2018 Steunstichting ESOT

AB - History of psychosis or mania, if uncontrolled, both represent relative contraindications for kidney transplantation. We examined 3680 US veterans who underwent kidney transplantation. The diagnosis of history of psychosis/mania was based on a validated algorithm. Measured confounders were used to create a propensity score-matched cohort (n = 442). Associations between pretransplantation psychosis/mania and death with functioning graft, all-cause death, graft loss, and rejection were examined in survival models and logistic regression models. Post-transplant medication nonadherence was assessed using proportion of days covered (PDC) for tacrolimus and mycophenolic acid in both groups. The mean ± SD age of the cohort at baseline was 61 ± 11 years, 92% were male, and 66% and 27% of patients were white and African-American, respectively. Compared to patients without history of psychosis/mania, patients with a history of psychosis/mania had similar risk of death with functioning graft [subhazard ratio (SHR) (95% confidence interval (CI)): 0.94(0.42–2.09)], all-cause death [hazard ratio (95% CI): 1.04 (0.51–2.14)], graft loss [SHR (95% CI): 1.07 (0.45–2.57)], and rejection [odds ratio(95% CI): 1.23(0.60–2.53)]. Moreover, there was no difference in immunosuppressive drug PDC in patients with and without history of psychosis/mania (PDC: 76 ± 21% vs. 78 ± 19%, P = 0.529 for tacrolimus; PDC: 78 ± 17% vs. 79 ± 18%, P = 0.666 for mycophenolic acid). After careful selection, pretransplantation psychosis/mania is not associated with adverse outcomes in kidney transplant recipients. © 2018 Steunstichting ESOT

KW - mycophenolic acid

KW - tacrolimus, adult

KW - African American

KW - age distribution

KW - all cause mortality

KW - Article

KW - Caucasian

KW - controlled study

KW - disease association

KW - female

KW - graft failure

KW - graft rejection

KW - human

KW - kidney transplantation

KW - major clinical study

KW - male

KW - mania

KW - medication compliance

KW - priority journal

KW - psychosis

KW - risk assessment

KW - risk factor

KW - sex difference

KW - treatment outcome

KW - veteran

KW - aged

KW - bipolar disorder

KW - cause of death

KW - complication

KW - middle aged

KW - mortality

KW - retrospective study, Aged

KW - Bipolar Disorder

KW - Cause of Death

KW - Female

KW - Graft Rejection

KW - Humans

KW - Kidney Transplantation

KW - Male

KW - Medication Adherence

KW - Middle Aged

KW - Psychotic Disorders

KW - Retrospective Studies

U2 - 10.1111/tri.13127

DO - 10.1111/tri.13127

M3 - Article

VL - 31

SP - 554

EP - 565

JO - Transplant International

JF - Transplant International

SN - 0934-0874

IS - 5

ER -